CRP and type 2 diabetes mellitus: This was, in part, to ensure broad-based utility, but also because novel biomarkers and specialised measurements such as serum high-sensitivity troponin T, plasma N-terminal pro-B-type natriuretic peptide, plasma high sensitivity C-reactive protein, and coronary artery calcification score await confirmation of a clinically relevant contribution to risk prediction over and above, or instead of, conventional risk factors in type 2 diabetes [33].